The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo

Journal of Immunology

Volumn 181, Issue 8, 2008, Pages 5510-5521

  Stevceva, Liljana ^a   Yoon, Victor ^a   Carville, Angela ^b   Pacheco, Beatriz ^b   Santosuosso, Michael ^a   Korioth Schmitz, Birgit ^b   Mansfield, Keith ^b   Poznansky, Mark C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN GP 120; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VIRUS ENVELOPE PROTEIN; GP120 PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; GP120 PROTEIN, SIMIAN IMMUNODEFICIENCY VIRUS; MEMBRANE PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DEGRANULATION; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VIVO STUDY; LYMPHOID TISSUE; MACACA; MONKEY DISEASE; NONHUMAN; PATHOGENESIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS SURVIVAL; ANIMAL; CD8+ T LYMPHOCYTE; CHO CELL; CRICETULUS; GENETICS; HAMSTER; IMMUNOLOGY; PATHOGENICITY; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHO CELLS; CRICETINAE; CRICETULUS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; IMMUNITY, CELLULAR; LYMPHOID TISSUE; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; VIRAL ENVELOPE PROTEINS;

EID: 54049134750     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.8.5510     Document Type: Article

References (87)

1. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68: 6103-6110.
2. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68: 4650-4655.
3. Burkhard, M. J., and G. A. Dean. 2003. Transmission and immunopathogenesis of FIV in cats as a model for HIV. Curr. HIV Res. 1: 15-29.
4. + T-lymphocyte proliferation and activation in acute simian immunodeficiency virus infection. J. Virol. 74: 8413-8424.
5. Pedersen, N. C., E. W. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235: 790-793.
6. + T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents. AIDS Res. Hum. Retroviruses 19: 487-495.
7. Kuroda, M. J., J. E. Schmitz, W. A. Charini, C. E. Nickerson, M. A. Lifton, C. I. Lord, M. A. Forman, and N. L. Letvin. 1999. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J. Immunol. 162: 5127-5133. (Pubitemid 29307114)
8. + T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr. Opin. Immunol. 12: 375-380.
9. Brander, C., and B. D. Walker. 1999. T lymphocyte responses in HIV-1 infection: implications for vaccine development. Curr. Opin. Immunol. 11: 451-459. (Pubitemid 29377915)
10. Goulder, P. J., and B. D. Walker. 1999. The great escape: AIDS viruses and immune control. Nat. Med. 5: 1233-1235.
11. Couillin, I., B. Culmann-Penciolelli, E. Gomard, J. Choppin, J. P. Levy, J. G. Guillet, and S. Saragosti. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 180: 1129-1134. (Pubitemid 24256625)
12. Goulder, P. J., R. E. Phillips, R. A. Colbert, S. McAdam, G. Ogg, M. A. Nowak, P. Giangrande, G. Luzzi, B. Morgan, A. Edwards, et al. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3: 212-217.
13. Koenig, S., A. J. Conley, Y. A. Brewah, G. M. Jones, S. Leath, L. J. Boots, V. Davey, G. Pantaleo, J. F. Demarest, C. Carter, et al. 1995. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1: 330-336.
14. Moore, C. B., M. John, I. R. James, F. T. Christiansen, C. S. Witt, and S. A. Mallal. 2002. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 296: 1439-1443.
15. Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. Bangham, C. R. Rizza, et al. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354: 453-459.
16. Price, D. A., P. J. Goulder, P. Klenerman, A. K. Sewell, P. J. Easterbrook, M. Troop, C. R. Bangham, and R. E. Phillips. 1997. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 94: 1890-1895.
17. Wolinsky, S. M., B. T. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, and J. T. Safrit. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272: 537-542. (Pubitemid 26138195)
18. Yang, O. O., P. T. Sarkis, A. Ali, J. D. Harlow, C. Brander, S. A. Kalams, and B. D. Walker. 2003. Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes. J. Exp. Med. 197: 1365-1375.
19. + T cell clones during primary HIV infection. Proc. Natl. Acad. Sci. USA 94: 9848-9853.
20. Zinkernagel, R. M. 1996. Immunology taught by viruses. Science 271: 173-178.
21. Algeciras, A., D. H. Dockrell, D. H. Lynch, and C. V. Paya. 1998. CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J. Exp. Med. 187: 711-720. (Pubitemid 28115187)
22. Brainard, D. M., W. G. Tharp, E. Granado, N. Miller, A. K. Trocha, X. H. Ren, B. Conrad, E. F. Terwilliger, R. Wyatt, B. D. Walker, and M. C. Poznansky. 2004. Migration of antigen-specific T cells away from CXCR4-binding human immunodeficiency virus type 1 gp120. J. Virol. 78: 5184-5193.
23. + T cells. J. Gen. Virol. 76: 681-690.
24. Finkel, T. H., G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV-and SIV-infected lymph nodes. Nat. Med. 1: 129-134.
25. Laurent-Crawford, A. G., B. Krust, Y. Riviere, C. Desgranges, S. Muller, M. P. Kieny, C. Dauguet, and A. G. Hovanessian. 1993. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res. Hum. Retroviruses 9: 761-773.
26. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497-500.
27. Pantaleo, G., H. Soudeyns, J. F. Demarest, M. Vaccarezza, C. Graziosi, S. Paolucci, M. Daucher, O. J. Cohen, F. Denis, W. E. Biddison, et al. 1997. Accumulation of human immunodeficiency virus-specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection. Eur. J. Immunol. 27: 3166-3173. (Pubitemid 28018011)
28. + lymphocyte depletion in rhesus monkeys. J. Virol. 71: 4218-4225.
29. Reimann, K. A., J. T. Li, R. Veazey, M. Halloran, I. W. Park, G. B. Karlsson, J. Sodroski, and N. L. Letvin. 1996. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J. Virol. 70: 6922-6928. (Pubitemid 26307405)
30. Klasse, P. J., and J. P. Moore. 2004. Is there enough gp120 in the body fluids of HIV-1-infected individuals to have biologically significant effects? Virology 323: 1-8.
31. + T-cell responses in mucosal tissues of macaques. J. Virol. 76: 11659-11676.
32. + intraepithelial lymphocytes in the mucosae of SIVmac251- or simian-human immunodeficiency virus KU2-infected macaques. Virology 319: 190-200.
33. Conley, A. J., M. K. Gorny, J. A. Kessler, 2nd, L. J. Boots, M. Ossorio-Castro, S. Koenig, D. W. Lineberger, E. A. Emini, C. Williams, and S. Zolla-Pazner. 1994. Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D. J. Virol. 68: 6994-7000.
34. Gorny, M. K., A. J. Conley, S. Karwowska, A. Buchbinder, J. Y. Xu, E. A. Emini, S. Koenig, and S. Zolla-Pazner. 1992. Neutralization of diverse human immunodeficiency virus type 1 variants by an anti-V3 human monoclonal antibody. J. Virol. 66: 7538-7542.
35. Gorny, M. K., T. C. VanCott, C. Hioe, Z. R. Israel, N. L. Michael, A. J. Conley, C. Williams, J. A. Kessler, 2nd, P. Chigurupati, S. Burda, and S. Zolla-Pazner. 1997. Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity. J. Immunol. 159: 5114-5122.
36. Gorny, M. K., J. Y. Xu, S. Karwowska, A. Buchbinder, and S. Zolla-Pazner. 1993. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J. Immunol. 150: 635-643. (Pubitemid 23133641)
37. Nyambi, P. N., M. K. Gorny, L. Bastiani, G. van der Groen, C. Williams, and S. Zolla-Pazner. 1998. Mapping of epitopes exposed on intact human immunodeficiency virus type 1 (HIV-1) virions: a new strategy for studying the immunologic relatedness of HIV-1. J. Virol. 72: 9384-9391.
38. Zolla-Pazner, S., J. O'Leary, S. Burda, M. K. Gorny, M. Kim, J. Mascola, and F. McCutchan. 1995. Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry. J. Virol. 69: 3807-3815.
39. Kent, K. A., L. Gritz, G. Stallard, M. P. Cranage, C. Collignon, C. Thiriart, T. Corcoran, P. Silvera, and E. J. Stott. 1991. Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. AIDS 5: 829-836.
40. Ball, J. M., K. E. Rushlow, C. J. Issel, and R. C. Montelaro. 1992. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies. J. Virol. 66: 732-742.
41. DeVico, A., R. C. Montelaro, R. C. Gallo, and M. G. Sarngadharan. 1991. Purification and partial characterization of equine infectious anemia virus reverse transcriptase. Virology 185: 387-394.
42. Hussain, K. A., C. J. Issel, K. L. Schnorr, P. M. Rwambo, and R. C. Montelaro. 1987. Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J. Virol. 61: 2956-2961.
43. + T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65. Clin. Diagn. Lab. Immunol. 8: 628-631.
44. + T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques. J. Virol. 75: 11483-11495.
45. Kern, F., I. P. Surel, C. Brock, B. Freistedt, H. Radtke, A. Scheffold, R. Blasczyk, P. Reinke, J. Schneider-Mergener, A. Radbruch, et al. 1998. T-cell epitope mapping by flow cytometry. Nat. Med. 4: 975-978.
46. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69: 4413-4422.
47. Jouvenet, N., S. J. Neil, C. Bess, M. C. Johnson, C. A. Virgen, S. M. Simon, and P. D. Bieniasz. 2006. Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 4: e435.
48. Sherer, N. M., M. J. Lehmann, L. F. Jimenez-Soto, A. Ingmundson, S. M. Horner, G. Cicchetti, P. G. Allen, M. Pypaert, J. M. Cunningham, and W. Mothes. 2003. Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4: 785-801.
49. Toapanta, F. R., J. K. Craigo, R. C. Montelaro, and T. M. Ross. 2007. Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope. Curr. HIV Res. 5: 199-209.
50. Berke, G. 1994. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu. Rev. Immunol. 12: 735-773. (Pubitemid 24140430)
51. Henkart, P. A. 1995. Apoptosis: O death, where is thy sting? J. Immunol. 154: 4905-4908.
52. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14: 207-232. (Pubitemid 26130183)
53. + T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78.
54. + regulatory T cells. Semin. Immunol. 16: 89-98.
55. Jonuleit, H., and E. Schmitt. 2003. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171: 6323-6327. (Pubitemid 37532056)
56. Mills, K. H. 2004. Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 4: 841-855. (Pubitemid 39490760)
57. Rouse, B. T., and S. Suvas. 2004. Regulatory cells and infectious agents: detentes cordiale and contraire. J. Immunol. 173: 2211-2215.
58. + regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods 319: 41-52.
59. + Treg cells. J. Exp. Med. 203: 1701-1711.
60. Nilsson, J., A. Boasso, P. A. Velilla, R. Zhang, M. Vaccari, G. Franchini, G. M. Shearer, J. Andersson, and C. Chougnet. 2006. HIV-1 driven regulatory T cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108: 3808-3817. (Pubitemid 44864563)
61. Romagnani, S. 2006. Regulation of the T cell response. Clin. Exp. Allergy 36: 1357-1366.
62. Mempel, T. R., M. J. Pittet, K. Khazaie, W. Weninger, R. Weissleder, H. von Boehmer, and U. H. von Andrian. 2006. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25: 129-141.
63. Addo, M. M., X. G. Yu, A. Rathod, D. Cohen, R. L. Eldridge, D. Strick, M. N. Johnston, C. Corcoran, A. G. Wurcel, C. A. Fitzpatrick, et al. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77: 2081-2092.
64. + T cells in HIV-infected progressors and long-term nonprogressors. J. Immunol. 165: 1082-1092.
65. Poli, G., G. Pantaleo, and A. S. Fauci. 1993. Immunopathogenesis of human immunodeficiency virus infection. Clin. Infect. Dis. 17 (Suppl. 1): S224-S229. (Pubitemid 23227136)
66. Brodie, S. J., D. A. Lewinsohn, B. K. Patterson, D. Jiyamapa, J. Krieger, L. Corey, P. D. Greenberg, and S. R. Riddell. 1999. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat. Med. 5: 34-41.
67. Lieberman, J., P. Shankar, N. Manjunath, and J. Andersson. 2001. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood 98: 1667-1677.
68. McMichael, A. J., and S. L. Rowland-Jones. 2001. Cellular immune responses to HIV. Nature 410: 980-987.
69. + T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions. J. Virol. 79: 6299-6311.
70. Williams, M. A., R. Trout, and S. A. Spector. 2002. HIV-1 gp120 modulates the immunological function and expression of accessory and co-stimulatory molecules of monocyte-derived dendritic cells. J. Hematother. Stem Cell Res. 11: 829-847.
71. Lopez, D., Y. Samino, U. H. Koszinowski, and M. Del Val. 2001. HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope. J. Immunol. 167: 4238-4244. (Pubitemid 32954297)
72. Fenoglio, D., G. Li Pira, L. Lozzi, L. Bracci, D. Saverino, P. Terranova, L. Bottone, S. Lantero, A. Megiovanni, A. Merlo, and F. Manca. 2000. Natural analogue peptides of an HIV-1 GP120 T-helper epitope antagonize response of GP120-specific human CD4 T-cell clones. J. Acquired Immune Defic. Syndr. 23: 1-7. (Pubitemid 30123259)
73. + T cell function by the HIV envelope protein, gp120. J. Immunol. 141: 3715-3717.
74. Ruegg, C. L., C. R. Monell, and M. Strand. 1989. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J. Virol. 63: 3257-3260. (Pubitemid 19181381)
75. Weinhold, K. J., H. K. Lyerly, S. D. Stanley, A. A. Austin, T. J. Matthews, and D. P. Bolognesi. 1989. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J. Immunol. 142: 3091-3097.
76. Di Rienzo, A. M., G. Furlini, R. Olivier, S. Ferris, J. Heeney, and L. Montagnier. 1994. Different proliferative response of human and chimpanzee lymphocytes after contact with human immunodeficiency virus type 1 gp120. Eur. J. Immunol. 24: 34-40. (Pubitemid 2006395)
77. Heeney, J., W. Bogers, L. Buijs, R. Dubbes, P. ten Haaft, W. Koornstra, H. Niphuis, P. Nara, and V. Teeuwsen. 1996. Immune strategies utilized by lentivirus infected chimpanzees to resist progression to AIDS. Immunol. Lett. 51: 45-52.
78. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78: 2454-2459.
79. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200: 331-343.
80. + regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104: 3249-3256.
81. Weiner, H. L. 2001. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol. Rev. 182: 207-214. (Pubitemid 33070220)
82. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
83. Moore, J. P., S. G. Kitchen, P. Pugach, and J. A. Zack. 2004. The CCR5 and CXCR4 coreceptors: central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 20: 111-126. (Pubitemid 38147183)
84. Blick, G., R. M. Kagan, E. Coakley, C. Petropoulos, L. Maroldo, P. Greiger-Zanlungo, S. Gretz, and T. Garton. 2007. The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient. J. Infect. Dis. 195: 1250-1259. (Pubitemid 46649609)
85. Markowitz, M., H. Mohri, S. Mehandru, A. Shet, L. Berry, R. Kalyanaraman, A. Kim, C. Chung, P. Jean-Pierre, A. Horowitz, et al. 2005. Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Lancet 365: 1031-1038. (Pubitemid 40386780)
86. Peut, V., and S. J. Kent. 2007. Utility of human immunodeficiency virus type 1 envelope as a T-cell immunogen. J. Virol. 81: 13125-13134. (Pubitemid 350156951)
87. + T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13: 46-53.